Cargando…
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States
The coronavirus-19 (COVID-19) pandemic poses a significant risk to patients undergoing hematopoietic stem cell transplantation (HCT) or cellular therapy. The American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Steering Committee aims to provide pharmacy practice...
Autores principales: | Mahmoudjafari, Zahra, Alexander, Maurice, Roddy, Julianna, Shaw, Ryan, Shigle, Terri Lynn, Timlin, Colleen, Culos, Katie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162779/ https://www.ncbi.nlm.nih.gov/pubmed/32305359 http://dx.doi.org/10.1016/j.bbmt.2020.04.005 |
Ejemplares similares
-
Position Statement on Opioid Analgesics in Pain Management – 2015 Update
Publicado: (2015) -
Position Statement on How to Manage Patients with Diabetes and COVID-19
Publicado: (2020) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021) -
Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association(*)
por: MacKay, Stuart G., et al.
Publicado: (2020) -
Public Statement on the Importance of Prevention and Management of Obesity and Metabolic Syndrome during the COVID-19 Pandemic
por: Lee, Chang Beom
Publicado: (2021)